FDA rules need tweaking
FDA rules need tweaking
The biotech industry is suffering a mini-crisis of confidence that mirrors the larger shocks that have sent Wall Street reeling.
FDA rules need tweaking
The biotech industry is suffering a mini-crisis of confidence that mirrors the larger shocks that have sent Wall Street reeling.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Leave a Reply
Want to join the discussion?Feel free to contribute!